Methylenedioxynitazene
Methylenedioxynitazene[edit | edit source]
Methylenedioxynitazene is a synthetic opioid analgesic that belongs to the nitazene class of drugs. It is known for its potent analgesic properties and has been a subject of interest due to its potential for abuse and overdose.
Chemical Structure and Properties[edit | edit source]
Methylenedioxynitazene is characterized by its complex chemical structure, which includes a methylenedioxy group attached to a nitazene backbone. This structure is responsible for its high affinity for the mu-opioid receptor, which is the primary target for opioid analgesics. The presence of the methylenedioxy group is thought to enhance the drug's potency compared to other nitazenes.
Pharmacology[edit | edit source]
Methylenedioxynitazene acts as a full agonist at the mu-opioid receptor, leading to potent analgesic effects. Its mechanism of action is similar to that of other opioids, where it mimics the effects of endogenous endorphins by binding to opioid receptors in the central nervous system. This binding results in the inhibition of neurotransmitter release, leading to decreased perception of pain.
Medical Use[edit | edit source]
Currently, Methylenedioxynitazene is not approved for medical use in humans. Its high potency and risk of overdose make it unsuitable for therapeutic applications without further research and development. However, it is of interest in the field of medicinal chemistry for the development of new analgesics.
Potential for Abuse[edit | edit source]
Like other opioids, Methylenedioxynitazene has a high potential for abuse. Its potency increases the risk of overdose, especially when used in combination with other central nervous system depressants such as benzodiazepines or alcohol. The drug's effects can lead to respiratory depression, which is the primary cause of fatal overdoses.
Legal Status[edit | edit source]
Due to its potential for abuse and lack of medical use, Methylenedioxynitazene is classified as a controlled substance in many jurisdictions. It is important for regulatory bodies to monitor its distribution and use to prevent illegal trafficking and misuse.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
